Business
Pfizer Sees About $15 Billion in 2021 Sales From COVID-19 Vaccine
Published by linker 5
Posted on February 2, 2021
1 min readLast updated: January 21, 2026
Add as preferred source on Google
Published by linker 5
Posted on February 2, 2021
1 min readLast updated: January 21, 2026
Add as preferred source on Google
(Reuters) – Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)
Explore more articles in the Business category











